Various described as "unleashing the power of genomics at scale", various Ultima Genomics personnel describe the firm's mission as that of driving the scale of genomic information to enable unprecedented advances in biology and improvements in human health. With such a powerful tool and the major need - soon and in many ways - requiring more genomic information to address biologyâs complexity and dynamic changeâ the irent need is to challenge conventional next-generation sequencing technologies. Management indicate that Ultimaâs very different - and new - sequencing architecture has the potential to drive down the costs of sequencing - lessening the need by scientists and clinicians make choices between the breadth, depth, and frequency with which they use genomic information. The new sequencing (lower cost of use) architecture developed and offered Ultima not only offers a scale far beyond conventional sequencing technologies but also is signfificantly lowering the cost of access to genomic information. Game cha
